Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05979688 · ClinicalTrials.gov registry record · NA

Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis

A NA study of Amyotrophic Lateral Sclerosis and Myasthenia Gravis, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT05979688 is a NA study of Amyotrophic Lateral Sclerosis and Myasthenia Gravis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 13 participants, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05979688, a NA study of Amyotrophic Lateral Sclerosis and Myasthenia Gravis, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to understand how well a 6-week virtual yogic breathing exercise program (YBEP) will improve breathing, speech, and emotional well-being in people with amyotrophic lateral sclerosis (ALS).

Interventions

  • BEHAVIORAL yogic breathing exercise

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2023-11-01
Est. Completion 2024-11-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT05979688

The ClinicalTrials.gov registry entry for NCT05979688 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (99% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which yogic breathing exercise is the first listed.

NCT05979688 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT05979688 about?

NCT05979688 is a clinical study titled "Yogic Breathing Exercise for People With Amyotrophic Lateral Sclerosis". The aim of this study is to understand how well a 6-week virtual yogic breathing exercise program (YBEP) will improve breathing, speech, and emotional well-being in people with amyotrophic lateral sclerosis (ALS).

What is the current status of trial NCT05979688?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2023-11-01. Estimated completion is 2024-11-01.

What conditions does trial NCT05979688 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Myasthenia Gravis.

What interventions are being tested in trial NCT05979688?

The interventions under investigation include: yogic breathing exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05979688?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05979688 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.